Sign in
DYN Stock Price, Chart, Stats & News
Dyne Therapeutics, Inc.
Save
3.36B
Market cap
–
Current P/E
–
Forward P/E
DYN chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -37.59% |
ROE | -61.45% |
D/E | 0.02x |
Interest coverage ratio | -75.61x |
DYN valuation
P/E | – |
P/S | – |
P/B | 2.26x |
P/CF | -5.46x |
P/FCF | -6.67x |
P/OCF | -5.46x |
PEG | -1.50x |
EV multiple | -8.45x |
About
Dyne Therapeutics, Inc. is a U. S.-based biotechnology firm focused on developing advanced treatments for genetically driven muscle disorders. Utilizing its proprietary FORCE platform, which is engineered to deliver disease-modifying therapeutics, the company is actively engaged in various programs.
Similar securities
Based on sector and market capitalization
Report issue